Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
NCT05612893 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2022-11-10
Summary
The goal of this observational study is to describe the immune signature of acute pulmonary infection.The main questions it aims to answer are:
1. Nasal mucosal immune response in patients with influenza infection
2. Difference of immune response between Viral sepsis and Bacterial sepsis
3. Immunological differences between Viral sepsis and Viral pneumonia
Conditions
- Sepsis
- Viral Pneumonia
- Influenza
- Upper Respiratory Tract Infection
Interventions
- OTHER
-
pathogen
The patients were divided into groups according to the pathogen(bacteria or virus). The influenza upper respiratory tract infection cohort will be grouped mainly according to age.
Sponsors & Collaborators
-
Capital Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-16
- Primary Completion
- 2025-04-10
- Completion
- 2025-09-10
Countries
- China
Study Locations
More Related Trials
-
Microecology and Host Immunity in Patients With Severe COVID-19 Infection
NCT05670275 ·Status: UNKNOWN
-
Rapid Diagnosis of Severe Respiratory Tract Infectious Diseases and Screening of Biomarkers for Stratified Diagnosis
NCT06533514 ·Status: NOT_YET_RECRUITING
-
Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients
NCT06566898 ·Status: RECRUITING
-
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
NCT06114784 ·Status: RECRUITING
-
Changes of Dendritic Cells in Acute Lung Injury
NCT02083393 ·Status: COMPLETED
-
Assessing Effectiveness of Community Acquired Pneumonia Treatment by Continuous Pneumonia Severity Score
NCT04135183 ·Status: UNKNOWN ·Phase: NA
-
Molecular Diagnosis and Prognosis of Severe Pulmonary Infection Immunosuppressed Hosts
NCT04395066 ·Status: UNKNOWN
-
The Association Mechanism Between the Microbiome and the Development of Community Pneumonia Was Studied Based on the Analysis of Pulmonary Microbiota - Host Interaction Network
NCT06896019 ·Status: ACTIVE_NOT_RECRUITING
-
Early Identification and Severity Prediction of Acute Respiratory Infectious Disease
NCT04955756 ·Status: UNKNOWN ·Phase: NA
-
Drug Resistance Factors In Healthcare-associated Pneumonia
NCT02736097 ·Status: COMPLETED
-
Lung Bacteriobiota and Influenza Mortality
NCT04131296 ·Status: UNKNOWN
-
Pathogen Identification of Bacterial Pneumonia Via DNA Detection
NCT00567827 ·Status: COMPLETED
-
Dynamic Pattern of Etiology, Immunoinflammatory Factors and Their Association With Prognosis of Severe Pneumonia
NCT06538441 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnosis and Treatment Strategy Optimization of Severe Pneumonia Based on Multi-omics Data Integration
NCT06288074 ·Status: RECRUITING
-
A Follow-up Study of Immune Dysregulation in Patients With COVID-19
NCT05669248 ·Status: UNKNOWN
-
A Validation Study on a Prognostic Prediction Model for Respiratory Tract Infections
NCT07109310 ·Status: NOT_YET_RECRUITING
-
Procalcitonin Role in Influenza Patients With Regard to Morbidity, Mortality and Antibiotic Use
NCT04171128 ·Status: COMPLETED
-
Evaluation of the American Thoracic Society Criteria for Predicting Multidrug-resistant Bacteria in Critically Ill Patients
NCT01667991 ·Status: COMPLETED
-
Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression
NCT05688774 ·Status: RECRUITING
-
Study on Immune Status of Patients With COVID-19
NCT05682573 ·Status: UNKNOWN
-
A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia
NCT02963142 ·Status: COMPLETED
-
The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing
NCT01236677 ·Status: UNKNOWN
-
mNGS for Detection of Pathogens for Pulmonary Infection
NCT03798925 ·Status: UNKNOWN
-
Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management
NCT04668170 ·Status: COMPLETED
-
Innate Immune Response During Community Acquired Pneumonia
NCT03379207 ·Status: TERMINATED